Victory Capital Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1K Buy
11,457
+174
+2% +$173 ﹤0.01% 2455
2026
Q1
$7.93K Sell
11,283
-30
-0.3% -$28 ﹤0.01% 2402
2025
Q4
$17.5K Buy
11,313
+75
+0.7% +$120 ﹤0.01% 2392
2025
Q3
$17.8K Sell
11,238
-441
-4% -$766 ﹤0.01% 2402
2025
Q2
$25.5K Sell
11,679
-121
-1% -$293 ﹤0.01% 2427
2025
Q1
$32.2K Sell
11,800
-244
-2% -$962 ﹤0.01% 2398
2024
Q4
$50.1K Sell
12,044
-245
-2% -$926 ﹤0.01% 2397
2024
Q3
$47.8K Buy
12,289
+409
+3% +$1.72K ﹤0.01% 2396
2024
Q2
$46.6K Sell
11,880
-115
-1% -$495 ﹤0.01% 2375
2024
Q1
$50.3K Sell
11,995
-321
-3% -$1.51K ﹤0.01% 2377
2023
Q4
$57.9K Buy
12,316
+2,306
+23% +$8.98K ﹤0.01% 2421
2023
Q3
$31.2K Buy
+10,010
New +$40.2K ﹤0.01% 2418

Other funds holding MXCT

Victory Capital Management's MXCT Position: Q2 2026 in Review

Victory Capital Management increased its MaxCyte (MXCT) stake by 1.5% in Q2 2026, buying an estimated $173 and bringing the position to 11,457 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Victory Capital Management first reported a position in MXCT in Q3 2023 and has held it in 12 quarters since. The position peaked at $57.9K in Q4 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Victory Capital Management held 11,457 shares of MaxCyte worth $14.1K as of Q2 2026.
  • Victory Capital Management bought 174 MaxCyte shares in Q2 2026, an estimated $173.
  • MaxCyte made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2455 holding.
  • Victory Capital Management first reported a position in MaxCyte in Q3 2023 and has held it in 12 quarters since.
  • Victory Capital Management's MaxCyte position peaked at $57.9K in Q4 2023.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.